Thermo Fisher Scientific stock raises guidance and trades at EUR 596.90
Published on 09/30/2026 at 16:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific stock was trading at EUR 596.90 at Lang & Schwarz on September 30, 2026, at 4:02 p.m. CEST. The company enters the next reporting cycle with higher full-year guidance after a second-quarter performance that exceeded its prior outlook, according to Yahoo Finance.
Q2 revenue rose 10 percent
In Q2 2026, Thermo Fisher reported revenue of USD 11.99 billion, up 10 percent year over year, while adjusted EPS increased 13 percent to USD 6.03. GAAP diluted EPS reached USD 4.68, a 9 percent increase, giving investors a clear split between statutory earnings and the company's adjusted performance.
Adjusted operating income rose 15 percent to USD 2.73 billion, and adjusted operating margin expanded 90 basis points to 22.80 percent. The results also included USD 1.678 billion of quarterly free cash flow and USD 1.0 billion of share repurchases, according to StockTitan in its summary of the July 23, 2026 filing.
Guidance now reaches USD 48.1 billion
Management raised 2026 revenue guidance to USD 47.4 billion to USD 48.1 billion, equivalent to 6 percent to 8 percent reported growth over 2025. Adjusted EPS guidance moved to USD 24.93 to USD 25.33, representing 9 percent to 11 percent growth and a USD 0.25 increase at the midpoint versus the previous outlook, as Yahoo Finance reported from the Q2 call.
The updated outlook puts the second half of 2026 at the center of the investment case. Management expects organic revenue growth of 4 percent in the second half, versus 3 percent in the first half, with pharma and biotech demand providing the main operating support. A counter-factor is the planned microbiology divestiture, which is expected to reduce 2026 revenue by USD 200 million net of retained channel sales.
Goldman lifts target to USD 780
Analyst sentiment also moved higher in September. Goldman Sachs raised its price target from USD 650.00 to USD 780.00 on September 21, 2026, while maintaining a Buy rating, according to Yahoo Finance. That target reflects a more constructive view than the prior target, but it remains an external assessment rather than company guidance.
October 21 is the next checkpoint
Thermo Fisher will release its third-quarter 2026 results before the market opens on October 21, 2026, followed by a conference call at 7:00 a.m. ET, according to the company's investor-relations announcement dated September 28, 2026, published by Thermo Fisher Scientific. The date gives the stock a defined test for whether the second-half growth profile is translating into another earnings beat.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz (as of September 30, 2026, 4:02 p.m. CEST): EUR 596.90
- Market capitalization: USD 249.8 billion (as of September 30, 2026)
- 52-week range: USD 435.27-682.98 (as of September 30, 2026)
- Sector / Industry: Healthcare / Medical - Diagnostics & Research
- Next earnings date: October 21, 2026
